adenoviral vector based COVID-19 vaccine (McMaster University)

N/A

Report date: 2025/03/14 16:36:38

Base Information

Drug Nameadenoviral vector based COVID-19 vaccine (McMaster University)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMcmaster University

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A